A2A PharmaMay 16, 20191 min readIrish Tech NewsUpdated: Feb 7, 2020Innovative new bio-technologies showcased; IndieBio Demo Day reviewedLEARN MORE
A2A co-founded biomea Fusion raises $56MBiomea Fusion, Inc., a precision oncology company dedicated to developing innovative medicines targeting genomically defined alterations...
A2A / Daewoong Pharmaceutical Oncology Agreement A2A Pharmaceuticals Inc. Today Announced a Multi-target Co-development Agreement With Daewoong Pharmaceutical for AI-enhanced Oncology...
Комментарии